Published in J Clin Endocrinol Metab on June 01, 1981
Gonadotropin-releasing hormone stimulation of luteinizing hormone release: A ligand-receptor-effector model. Proc Natl Acad Sci U S A (1982) 0.90
Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease. Clin Exp Immunol (1984) 0.83
Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease. CMAJ (1986) 0.81
Studies on multiple thyroid cell membrane-directed antibodies in Graves' disease. J Clin Invest (1985) 0.81
Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. J Clin Invest (1983) 0.78
Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies. J Clin Invest (1984) 0.76
Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease. Korean J Intern Med (1988) 0.75
Characteristics of anti-TSH antibody and its relationship with TSH receptor antibody. Korean J Intern Med (1988) 0.75
Thyrotoxicosis: gross acropachy and pretibial myxoedema. J R Soc Med (1986) 0.75
Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet (1994) 4.36
Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest (1970) 3.64
Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet (1994) 3.39
EXPERIMENTS IN HUMAN VOLUNTEERS WITH TRACHOMA AND INCLUSION CONJUNCTIVITIS AGENT. Br J Ophthalmol (1962) 3.18
P[Switch], a system for spatial and temporal control of gene expression in Drosophila melanogaster. Proc Natl Acad Sci U S A (2001) 2.92
FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology (2001) 2.46
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
In vivo degradation of resin-dentin bonds in humans over 1 to 3 years. J Dent Res (2000) 2.30
A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J Clin Invest (1965) 2.29
Stimulation by phagocytosis of the deiodination of L-thyroxine in human leukocytes. Science (1972) 2.26
The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet (1993) 2.18
Hrs is associated with STAM, a signal-transducing adaptor molecule. Its suppressive effect on cytokine-induced cell growth. J Biol Chem (1997) 2.03
Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol (1989) 1.95
Focal nodular hyperplasia of the liver: direct evidence of circulatory disturbances. J Gastroenterol Hepatol (2000) 1.78
Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter. N Engl J Med (1969) 1.70
Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J Clin Endocrinol Metab (1975) 1.62
Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med (1980) 1.53
Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects. J Neurol Neurosurg Psychiatry (2002) 1.52
Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med (1993) 1.52
HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatr Scand (2005) 1.51
Use of contrast-enhanced computed tomography to measure clearance per unit renal volume: a novel measurement of renal function and fractional vascular volume. Am J Kidney Dis (1999) 1.49
Pure word deafness and pure anarthria in a patient with frontotemporal dementia. Eur J Neurol (2007) 1.49
Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA. J Nucl Med (1995) 1.47
Drosophila fasciclinII is required for the formation of odor memories and for normal sensitivity to alcohol. Cell (2001) 1.45
The binding of thyrotropin to isolated bovine thyroid plasma membranes. J Biol Chem (1973) 1.43
Treatment of small-cell lung cancer xenografts with iodine-131-anti-neural cell adhesion molecule monoclonal antibody and evaluation of absorbed dose in tissue. J Nucl Med (1994) 1.42
Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab (1978) 1.42
Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence. Surgery (1996) 1.41
FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses. Skeletal Radiol (2003) 1.41
The effects of an acute load of thyroxine on the transport and peripheral metabolism of triiodothyronine in man. J Clin Invest (1970) 1.41
Hepatocyte response to continuous low dose-rate radiation in radioimmunotherapy assessed by micronucleus assay. Int J Radiat Biol (1992) 1.39
Grf40, A novel Grb2 family member, is involved in T cell signaling through interaction with SLP-76 and LAT. J Exp Med (1999) 1.39
High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome. Acta Paediatr (1992) 1.38
An extraordinarily high CA 125 level in a woman without apparent pathologic foci of CA 125 production: dissociation between serum levels of CA 125 and CA 130. Am J Obstet Gynecol (1991) 1.38
Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease. Hum Mol Genet (1995) 1.36
Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration. J Clin Endocrinol Metab (1971) 1.34
The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. J Clin Invest (1970) 1.34
Mode of inhibition of beta-hydroxydecanoyl thioester dehydrase by 3-decynoyl-N-acetylcysteamine. J Biol Chem (1970) 1.34
Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology (1986) 1.33
The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. J Clin Endocrinol Metab (1974) 1.32
Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen. Cancer (1990) 1.32
Cyclic outbreaks of Japanese encephalitis among pigs and humans. Am J Epidemiol (1966) 1.30
Antiinflammatory principles of Atractylodes rhizomes. Chem Pharm Bull (Tokyo) (1979) 1.29
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest (1965) 1.28
Sonography of Hashimoto's thyroiditis. J Clin Ultrasound (1986) 1.28
The contribution of thyroxine-binding prealbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J Clin Invest (1968) 1.26
Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem (1998) 1.24
STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity (1997) 1.24
XIAP regulates DNA damage-induced apoptosis downstream of caspase-9 cleavage. J Biol Chem (2000) 1.22
Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res (2000) 1.21
Iodide-induced thyrotoxicosis in Boston. N Engl J Med (1972) 1.18
Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents. J Clin Invest (1979) 1.18
Decreased serum testosterone concentration in male heroin and methadone addicts. Steroids (1973) 1.18
Novel phenylalanine dehydrogenases from Sporosarcina ureae and Bacillus sphaericus. Purification and characterization. J Biol Chem (1987) 1.18
Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture. Oncogene (1992) 1.16
Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine. Tumour Biol (1996) 1.16
Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. J Physiol (1992) 1.16
Factors influencing peripheral nerve stimulation produced inhibition of primate spinothalamic tract cells. Pain (1984) 1.16
The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver. J Clin Invest (1978) 1.16
Dietary-induced alterations in thyroid hormone metabolism during overnutrition. J Clin Invest (1979) 1.15
Novel alpha-amylase that is highly resistant to chelating reagents and chemical oxidants from the alkaliphilic Bacillus isolate KSM-K38. Appl Environ Microbiol (2001) 1.15
The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol (2009) 1.15
Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Commun (1988) 1.15
Mechanism and significance of myocardial uptake of antimyosin antibody in myocarditis and cardiomyopathy: clinical and experimental studies. Clin Immunol Immunopathol (1993) 1.13
Spatiotemporally differential inhibition of pyramidal cells in the cat motor cortex. J Neurophysiol (1994) 1.13
Degradation of benzenesulfonate to sulfite in bacterial extract. J Biochem (1977) 1.13
Abnormal thyroid function and response to iodides in patients with cystic fibrosis. Trans Assoc Am Physicians (1974) 1.13
Familial dysalbuminemic hyperthyroxinemia: a syndrome that can be confused with thyrotoxicosis. N Engl J Med (1982) 1.13
Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci (2000) 1.12
Control of thyroid hormone secretion in normal subjects receiving iodides. J Clin Invest (1973) 1.12
Management of emergencies. IX. Thyrotoxic storm. N Engl J Med (1966) 1.12
Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure. Kidney Int Suppl (1997) 1.12
Comparison of in situ gelling formulations for the oral delivery of cimetidine. Int J Pharm (2001) 1.11
Ischaemic ileal stenosis following blunt abdominal trauma and demonstrated by CT. Br J Radiol (2001) 1.11
Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine. J Endocrinol Invest (1982) 1.11
Autoregulation of the thyroid. Response to iodide excess and depletion. Mayo Clin Proc (1972) 1.10
Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period. Virchows Arch (1999) 1.09
Observations concerning the binding of thyroid hormones in sera of normal subjects of varying ages. J Clin Invest (1966) 1.08
Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J Clin Invest (1973) 1.08
Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest (1970) 1.08
Active form of the thyroid hormone. Annu Rev Med (1975) 1.08
Preferential induction of rough variants in Streptococcus mutans by ethidium bromide. J Dent Res (1973) 1.07
Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science (1983) 1.07
Metabolism of L-thyroxine by phagocytosing human leukocytes. J Clin Invest (1973) 1.07
Stimulation of mitochondrial adenosine diphosphate uptake by thyroid hormones. Proc Natl Acad Sci U S A (1973) 1.07
Cat peripheral nerve regeneration across 50 mm gap repaired with a novel nerve guide composed of freeze-dried alginate gel. Neurosci Lett (1999) 1.07
The mitochondrial genome of the brachiopod Laqueus rubellus. Genetics (2000) 1.06
c-erbB-2 protein is expressed in hepatolithiasis and cholangiocarcinoma. Histopathology (1998) 1.06
A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem (1993) 1.06
Resin-tooth adhesive interfaces after long-term function. Am J Dent (2001) 1.06
Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes. J Clin Invest (1979) 1.06
Long-lasting synaptic facilitation induced by serotonin in superficial dorsal horn neurones of the rat spinal cord. J Physiol (1996) 1.06
Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J Biochem (1993) 1.04
Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease. J Clin Endocrinol Metab (1971) 1.04
Studies of the mechanism by which 3,5,3'- triiodothyronine stimulates 2-deoxyglucose uptake in rat thymocytes in vitro. Role of calcium and adenosine 3':5'-monophosphate. J Clin Invest (1981) 1.03
Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema. J Clin Endocrinol Metab (1983) 1.02
Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado-Joseph disease. Ann Neurol (1998) 1.02
Biodistribution studies on L-3-[fluorine-18]fluoro-alpha-methyl tyrosine: a potential tumor-detecting agent. J Nucl Med (1998) 1.02
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning. J Bone Joint Surg Br (2000) 1.01